Jason A Keyes Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jason A Keyes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jason A Keyes. Jason A Keyes is EVP, Chief Financial Officer in Orexigen Therapeutics, Inc. ($OREX) and SVP, Chief Financial Officer in Orexigen Therapeutics, Inc. ($OREX) and Director in Sesen Bio, Inc. ($SESN) and Chief Financial Officer in Equillium, Inc. ($EQ).
Latest Insider Trading Transactions of Jason A Keyes
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EQ, OREX, SESN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Sell | S | 6.50 | 5,000 | 32,484 | 115,720 | 120.7 K to 115.7 K (-4.14 %) |
| May 05 2021 | SESN | Sesen Bio, Inc. | Keyes Jason A | Director | Option Exercise | A | 2.79 | 92,500 | 258,075 | 92,500 | |
| Dec 28 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Sell | S | 4.74 | 8,000 | 37,914 | 120,720 | 128.7 K to 120.7 K (-6.22 %) |
| May 08 2020 | SESN | Sesen Bio, Inc. | Keyes Jason A | Director | Option Exercise | A | 0.63 | 59,000 | 37,135 | 59,000 | |
| Apr 24 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Option Exercise | A | 2.45 | 90,000 | 220,500 | 90,000 | |
| Apr 24 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Option Exercise | D | 4.75 | 90,000 | 427,500 | 0 | |
| Apr 24 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Option Exercise | A | 2.45 | 70,000 | 171,500 | 70,000 | |
| Apr 24 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Option Exercise | D | 7.16 | 70,000 | 501,200 | 0 | |
| Feb 26 2020 | SESN | Sesen Bio, Inc. | Keyes Jason A | Director | Option Exercise | A | 0.82 | 118,000 | 97,043 | 118,000 | |
| Feb 19 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Sell | S | 5.03 | 5,000 | 25,138 | 130,520 | 135.5 K to 130.5 K (-3.69 %) |
| Jan 22 2020 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Sell | S | 4.41 | 5,000 | 22,043 | 135,520 | 140.5 K to 135.5 K (-3.56 %) |
| Dec 12 2019 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Option Exercise | A | 4.75 | 90,000 | 427,500 | 90,000 | |
| Sep 04 2019 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Sell | S | 3.60 | 5,000 | 17,981 | 138,720 | 143.7 K to 138.7 K (-3.48 %) |
| Aug 05 2019 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Sell | S | 3.99 | 5,000 | 19,941 | 143,720 | 148.7 K to 143.7 K (-3.36 %) |
| Feb 15 2019 | EQ | Equillium, Inc. | Keyes Jason A | Chief Financial Off ... | Option Exercise | A | 7.16 | 70,000 | 501,200 | 70,000 | |
| Oct 17 2017 | OREX | Orexigen Therapeut ... | Keyes Jason A | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 69,600 | 0 | 69,600 | |
| Jun 02 2017 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Grant | A | 1.55 | 557 | 863 | 3,031 | 2.5 K to 3 K (+22.51 %) |
| Feb 07 2017 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 43,500 | 652,500 | 43,500 | |
| Feb 07 2017 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 4.10 | 87,000 | 356,700 | 87,000 | |
| Dec 02 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Grant | A | 1.67 | 291 | 486 | 2,474 | 2.2 K to 2.5 K (+13.33 %) |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 15,750 | 236,250 | 15,750 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 78,750 | 1,181,250 | 78,750 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 4.02 | 26,250 | 105,525 | 26,250 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 4.02 | 131,250 | 527,625 | 131,250 |
Page: 1